Actively Recruiting
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Led by Johns Hopkins University · Updated on 2026-03-02
5000
Participants Needed
1
Research Sites
732 weeks
Total Duration
On this page
Sponsors
J
Johns Hopkins University
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The aims of this study are to determine the natural history of pancreatic cysts and to propose and prospectively validate a diagnostic approach and model for prediction of mucinous versus non-mucinous, and malignant versus non-malignant, pancreatic cysts using a combination of clinical, radiologic, and biomarker characteristics.
CONDITIONS
Official Title
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients age 18 years and older
- Referred for assessment of a pancreatic cyst.
You will not qualify if you...
- Medically ill patients with American Society of Anesthesiologists class 4 or greater
- Inability to provide informed consent
- Pregnancy or lactation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
Actively Recruiting
Research Team
E
Elham Afghani, MD MPH
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here